Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 12
Submit an article Journal homepage
542
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity

Kohei Kaku Diabetes and Endocrine Division, Department of Medicine, Kawasaki Medical School, Okayama, JapanCorrespondence[email protected]
,
Hiroyuki Daida Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan
,
Atsunori Kashiwagi Department of Medicine, Shiga University of Medical Science, Shiga, Japan
,
Akira Yamashina Second Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
,
Tsutomu Yamazaki Department of Clinical Epidemiology & Systems, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
,
Shin-ichi Momomura Saitama Medical Center, Jichi Medical University, Saitama, Japan
,
Takashi Iwase Iwase Internal Medicine Cardiology Clinic, Tokyo, Japan
,
Yoshimitsu Yamasaki Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
,
Kazuyuki Nagatsuka Cerebrovascular Division, Department of Internal Medicine, National Cardiovascular Center, Osaka, Japan
,
Kazuo Kitagawa Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
&
Ryuzo Kawamori Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, Tokyo, Japan
 show all
Pages 2925-2932 | Accepted 11 Sep 2009, Published online: 16 Oct 2009

References

  • Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 2004;16:434-44
  • Khaw K-T, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 2001;322:1-6
  • Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 1996;45(Suppl. 3):S14-16
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-53
  • UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65
  • Stettler C, Allemann S, Juni P, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 2006;152:27-38
  • Bolen S, Feldman L, Vassy J, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes. Ann Int Med 2007;147:386-99
  • Pfützner A, Schneider CA, Forst T. Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effects. Expert Rev Cardiovasc Ther 2006;4:445-59
  • Mazzone T, Meyer PM, Feinstein SB, et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes. JAMA 2006;296:2572-81
  • Nissen SE, Nicholls SJ, Wolski K, et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized, controlled trial. JAMA 2008;299:1561-73
  • Dormandy JA, Charbonnel B, Eckland DJA, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. Lancet 2005;366:1279-89
  • Lincoff AM, Wolski K, Nicholls SJ, et al. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus. JAMA 2007;298:1180-8
  • Mita T, Watada H, Shimizu T, et al. Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol 2007;27:2456-62
  • Hanefeld M, Louis Chiasson J, Koehler C, et al. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004;35:1073-8
  • Sone H, Mizuno S, Fuji H, et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients?. Diabetes Care 2005;48:1463-71
  • Campbell IW Long-term glycemic control with pioglitazone in patients with type 2 diabetes. Int J Clin Pract 2004;58:192-200

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.